Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Карцинома Меркеля
Карцинома Меркеля
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
В обзоре представлено описание рака кожи из клеток Меркеля, возможных этиологических факторов и механизмов развития, методов диагностики, дифференциальной диагностики и вариантов лечения.
Ключевые слова: рак кожи из клеток Меркеля, нейроэндокринный рак кожи, нейронспецифическая енолаза, хромогранин А.
Key words: merkel cell carcinoma, neuroendocrine carcinoma of the skin, neuronspecific enolase, сhromogranin A.
Ключевые слова: рак кожи из клеток Меркеля, нейроэндокринный рак кожи, нейронспецифическая енолаза, хромогранин А.
________________________________________________
Key words: merkel cell carcinoma, neuroendocrine carcinoma of the skin, neuronspecific enolase, сhromogranin A.
Полный текст
Список литературы
1. Toker C. Trabecular carcinoma of the skin. Arch dermatology 1972; 105: 107–10.
2. Robert A. Schwartz Skin Cancer. Recognition and Management 2008; 13: 220–5.
3. Iyer J, Thibodeau R, Nghiem P. Merkel Cell Carcinoma. ASCO еducational book 2010; p. 343–8.
4. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Sience 2008; 319: 1096–100.
5. Goessling W, McKee P, Mayer R. Merkel cell carcinoma. J Clin Oncol 2002; 20: 558–98.
6. Rigel DS. Cancer of the skin. Elsevier 2005; p. 323–7.
7. Becker JC. Merkel cell carcinoma. Annals of Oncology 2010; 21 (Suppl. 7).
8. AJCC Cancer Staging Manual. 7th Ed 2010; p. 315.
9. Gould VE, Moll R, Moll I. Neuroendocrine (Merkel) cells of the skin: hyperplasia, dysplasias and neoplasms. Lab Invest 1985; 52 (4): 334–53.
10. Saito A, Tsutsumida A, Furukawa H et al. Merkel cell carcinoma of the face: an analysis of 16 cases in the Japanese. Journal Plast Reconstr Aesthet Surg; 2008. – doi:10.1016/j.bjps.2008.03.027.
11. Dancey AL, Rayatt SS, Soon C et al. Merkel cell carcinoma: a report of 34 cases and literature review. J Plast Reconstr Aesthet Surg 2006; 59: 1294–9.
12. Allen PJ, Bowne WB, Jaques DP et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clini Oncol 2005; 23: 2300–9.
13. Allen PJ, Zhahg ZF, Coit DG. Surgical management of Merkel cell carcinoma. Ann Surg 1999; 229: 97–105.
14. Messina JL, Reintgen DS, Cruse CW et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 1997; 4: 389–95.
15. Lewis KG, Weinstock MA, Weaver AL et al. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatology 2006; 142: 693–700.
16. Eng TY, Boersma MG, Fuller CD et al. A comprehensive review of the treatment of Merkel cell carcinoma. Am J Clini Oncol 2007; 30: 624–36.
17. Samlowski WE, Moon J, Tuthill RJ et al. A phase II trial of imatinib mesylate in Merkel cell carcinoma: a Southwest Oncology Group Study. J Clin Oncol 2009; 27 (Suppl. 20. Abstr. 9056).
18. Davids MS, Charlton A, Ng SS et al. Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma. J Clin Oncol 2009; 27 (26): 97–100.
19. Di Bartolomeo M, Bajetta E, Buzzoni R et al. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group. Cancer 1996; 77: 402–8.
20. Ben Shlomo A, Melmed S. Pasireotide – a somatostatin analog for the potential treatment of acromegaly, neuroendocrine tumors and Cushing’s disease. I Drugs 2007; 10: 885–95.
21. Becker J, Mauch С et al. Short German guidelines: Merkel cell carcinoma. J Сompil Blackwell Verlag, Berlin 2008; (Suppl. 1): S15–S16.
2. Robert A. Schwartz Skin Cancer. Recognition and Management 2008; 13: 220–5.
3. Iyer J, Thibodeau R, Nghiem P. Merkel Cell Carcinoma. ASCO еducational book 2010; p. 343–8.
4. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Sience 2008; 319: 1096–100.
5. Goessling W, McKee P, Mayer R. Merkel cell carcinoma. J Clin Oncol 2002; 20: 558–98.
6. Rigel DS. Cancer of the skin. Elsevier 2005; p. 323–7.
7. Becker JC. Merkel cell carcinoma. Annals of Oncology 2010; 21 (Suppl. 7).
8. AJCC Cancer Staging Manual. 7th Ed 2010; p. 315.
9. Gould VE, Moll R, Moll I. Neuroendocrine (Merkel) cells of the skin: hyperplasia, dysplasias and neoplasms. Lab Invest 1985; 52 (4): 334–53.
10. Saito A, Tsutsumida A, Furukawa H et al. Merkel cell carcinoma of the face: an analysis of 16 cases in the Japanese. Journal Plast Reconstr Aesthet Surg; 2008. – doi:10.1016/j.bjps.2008.03.027.
11. Dancey AL, Rayatt SS, Soon C et al. Merkel cell carcinoma: a report of 34 cases and literature review. J Plast Reconstr Aesthet Surg 2006; 59: 1294–9.
12. Allen PJ, Bowne WB, Jaques DP et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clini Oncol 2005; 23: 2300–9.
13. Allen PJ, Zhahg ZF, Coit DG. Surgical management of Merkel cell carcinoma. Ann Surg 1999; 229: 97–105.
14. Messina JL, Reintgen DS, Cruse CW et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 1997; 4: 389–95.
15. Lewis KG, Weinstock MA, Weaver AL et al. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatology 2006; 142: 693–700.
16. Eng TY, Boersma MG, Fuller CD et al. A comprehensive review of the treatment of Merkel cell carcinoma. Am J Clini Oncol 2007; 30: 624–36.
17. Samlowski WE, Moon J, Tuthill RJ et al. A phase II trial of imatinib mesylate in Merkel cell carcinoma: a Southwest Oncology Group Study. J Clin Oncol 2009; 27 (Suppl. 20. Abstr. 9056).
18. Davids MS, Charlton A, Ng SS et al. Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma. J Clin Oncol 2009; 27 (26): 97–100.
19. Di Bartolomeo M, Bajetta E, Buzzoni R et al. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group. Cancer 1996; 77: 402–8.
20. Ben Shlomo A, Melmed S. Pasireotide – a somatostatin analog for the potential treatment of acromegaly, neuroendocrine tumors and Cushing’s disease. I Drugs 2007; 10: 885–95.
21. Becker J, Mauch С et al. Short German guidelines: Merkel cell carcinoma. J Сompil Blackwell Verlag, Berlin 2008; (Suppl. 1): S15–S16.
Авторы
К.В.Орлова, Н.Ф.Орел, А.А.Маркович, Л.В.Демидов
ФГБУ Российский онкологический научный центр им. Н.Н.Блохина РАМН
ФГБУ Российский онкологический научный центр им. Н.Н.Блохина РАМН
________________________________________________
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.